RBC Transfusion Strategies in the ICU: A Concise Review
Authors:
- 1 November 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 47 (11) , 1637-1644
Abstract
Objectives: To critically assess available high-level clinical studies regarding RBC transfusion strategies, with a focus on hemoglobin transfusion thresholds in the ICU. Data Sources: Source data were obtained from a PubMed literature review. Study Selection: English language studies addressing RBC transfusions in the ICU with a focus on the most recent relevant studies. Data Extraction: Relevant studies were reviewed and the following aspects of each study were identified, abstracted, and analyzed: study design, methods, results, and implications for critical care practice. Data Synthesis: Approximately 30–50% of ICU patients receive a transfusion during their hospitalization with anemia being the indication for 75% of transfusions. A significant body of clinical research evidence supports using a restrictive transfusion strategy (e.g., hemoglobin threshold < 7 g/dL) compared with a more liberal approach (e.g., hemoglobin threshold < 10 g/dL). A restrictive strategy (hemoglobin < 7 g/dL) is recommended in patients with sepsis and gastrointestinal bleeds. A slightly higher restrictive threshold is recommended in cardiac surgery (hemoglobin < 7.5 g/dL) and stable cardiovascular disease (hemoglobin < 8 g/dL). Although restrictive strategies are generally supported in hematologic malignancies, acute neurologic injury, and burns, more definitive studies are needed, including acute coronary syndrome. Massive transfusion protocols are the mainstay of treatment for hemorrhagic shock; however, the exact RBC to fresh frozen plasma ratio is still unclear. There are also emerging complimentary practices including nontransfusion strategies to avoid and treat anemia and the reemergence of whole blood transfusion. Conclusions: The current literature supports the use of restrictive transfusion strategies in the majority of critically ill populations. Continued studies of optimal transfusion strategies in various patient populations, coupled with the integration of novel complementary ICU practices, will continue to enhance our ability to treat critically ill patients.Keywords
This publication has 83 references indexed in Scilit:
- A Randomized Controlled Pilot Trial of Modified Whole Blood versus Component Therapy in Severely Injured Patients Requiring Large Volume TransfusionsAnnals of Surgery, 2013
- Blood transfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patientsJournal of Cardiothoracic Surgery, 2013
- The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) StudyJAMA Surgery, 2013
- Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injuryCritical Care, 2012
- Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trialTrials, 2011
- Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass SurgeryCirculation: Cardiovascular Quality and Outcomes, 2009
- Anemia and red blood cell transfusion in neurocritical careCritical Care, 2009
- Efficacy and Safety of Epoetin Alfa in Critically Ill PatientsNew England Journal of Medicine, 2007
- Predictors of Extubation Outcome in Patients Who Have Successfully Completed a Spontaneous Breathing TrialChest, 2001
- Anesthesia in Cases of Poor Surgical RiskAnesthesiology, 1942